Skip to main content

Clinical Trials

COVALENT-101

A phase 1 clinical trial for patients with relapsed or refractory AML, ALL, DLBCL, MM or CLL/SLL.


COVALENT-102

A phase 1/1b clinical trial for patients with KRAS mutant, unresectable, locally advanced/metastatic NSCLC, PDAC, and CRC.

COVALENT-111

A phase 1/2 clinical trial in healthy adults and adults with Type 2 diabetes.



COVALENT-103

A Phase 1 clinical trial for adults with FLT3 mutant Acute Leukemia.